These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 31426846)

  • 1. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice.
    Yin Y; Hao H; Cheng Y; Zang L; Liu J; Gao J; Xue J; Xie Z; Zhang Q; Han W; Mu Y
    Cell Death Dis; 2018 Jul; 9(7):760. PubMed ID: 29988034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.
    Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y
    Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
    Zhang M; Zhou Z; Wang J; Li S
    Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.
    Si Y; Zhao Y; Hao H; Liu J; Guo Y; Mu Y; Shen J; Cheng Y; Fu X; Han W
    Diabetes; 2012 Jun; 61(6):1616-25. PubMed ID: 22618776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.
    Yu S; Cheng Y; Zhang L; Yin Y; Xue J; Li B; Gong Z; Gao J; Mu Y
    Stem Cell Res Ther; 2019 Nov; 10(1):333. PubMed ID: 31747961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes.
    Wang M; Song L; Strange C; Dong X; Wang H
    Mol Ther; 2018 Aug; 26(8):1921-1930. PubMed ID: 30005867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy.
    Jin L; Deng Z; Zhang J; Yang C; Liu J; Han W; Ye P; Si Y; Chen G
    J Transl Med; 2019 Aug; 17(1):251. PubMed ID: 31382970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-495 regulates macrophage M1/M2 polarization and insulin resistance in high-fat diet-fed mice via targeting FTO.
    Hu F; Tong J; Deng B; Zheng J; Lu C
    Pflugers Arch; 2019 Dec; 471(11-12):1529-1537. PubMed ID: 31709454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
    Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
    Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats.
    Hu J; Wang F; Sun R; Wang Z; Yu X; Wang L; Gao H; Zhao W; Yan S; Wang Y
    Endocrine; 2014 Mar; 45(2):279-87. PubMed ID: 23686639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells Promote Diabetic Corneal Epithelial Wound Healing Through TSG-6-Dependent Stem Cell Activation and Macrophage Switch.
    Di G; Du X; Qi X; Zhao X; Duan H; Li S; Xie L; Zhou Q
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4344–4354. PubMed ID: 28810264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
    Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
    Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems.
    Kotikalapudi N; Sampath SJP; Sukesh Narayan S; R B; Nemani H; Mungamuri SK; Venkatesan V
    Sci Rep; 2021 Aug; 11(1):16983. PubMed ID: 34417511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
    Zhang Z; Niu L; Tang X; Feng R; Yao G; Chen W; Li W; Feng X; Chen H; Sun L
    Nephrol Dial Transplant; 2019 Apr; 34(4):597-605. PubMed ID: 29982691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.